Management of "bad trips" in an evolving drug scene.
D000661:Amphetamine / Q000009:adverse effects; D002188:Cannabis / Q000009:adverse effects; D002746:Chlorpromazine / Q000627:therapeutic use; D004340:Drug Contamination; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced; D009892:Opium / Q000009:adverse effects; D010640:Phenothiazines / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D011613:Psychotherapy; D019966:Substance-Related Disorders
D006213:Hallucinogens; D010640:Phenothiazines; D009892:Opium; D000661:Amphetamine; D002746:Chlorpromazine